ISLAMABAD: Minister for National Health Services, Regulations and Coordination Abdul Qadir Patel said that pharmaceutical company GSK has continued its manufacturing and supplying of Panadol products in Pakistan.

Talking to media, he denied media reports regarding suspension of Panadol products from GlaxoSmithKline Consumer Healthcare Pakistan Ltd (GSK) in Pakistan. “We want to facilitate pharmaceutical industry in country and pricing issue of medicine concerned is being discussed with relevant quarters.” He said that a meeting was held in this regard to discuss various aspects.

“Incumbent government will take a decision keeping in view difficulties of general public.” Meanwhile, GlaxoSmithKline Consumer Healthcare Pakistan Ltd said that GSK has continued to manufacture and supply Panadol products and made it clear that company has not stopped its production of Panadol products as reported in some sections of media. “We have been an integral part of health sector for many years and contributing to economic growth and stability of Pakistan with our products and local manufacturing footprint”, GSK representative said in a company’s press release.

He expressed hope that ministry will address their genuine issues including rationalised pricing to ensure delivering better healthcare services to Pakistanis. An official of Pakistan Pharmaceutical Manufacturers Association said that despite challenges, pharma company has continued production of Panadol products for patients.

Published in The Daily National Courier, October, 27 2022

Like Business on Facebook, follow @DailyNCourier on Twitter to stay informed and join in the conversation.